Sotera Health Co 8-K

What Happened

• Sotera Health Company filed an 8-K on February 24, 2026 announcing its financial results for the quarter and year ended December 31, 2025 (press release attached as Exhibit 99.1). The company will host a conference call on February 24, 2026 at 9:00 a.m. ET to discuss the results and its full‑year 2026 outlook.
• Separately, Senior Vice President and General Counsel Alex Dimitrief notified the company he will retire effective March 31, 2026. He is expected to be retained as an advisor beginning April 1, 2026 to assist with ethylene oxide litigation matters. Erika Ostrowski, currently Vice President, Deputy General Counsel and Corporate Secretary, will be promoted to Senior Vice President and General Counsel effective April 1, 2026.

Key Details

• Press release and results date: February 24, 2026; reporting period: quarter and year ended December 31, 2025.
• Conference call: February 24, 2026 at 9:00 a.m. Eastern Time to discuss results and 2026 outlook.
• Executive transition: Alex Dimitrief retires March 31, 2026; Erika Ostrowski promoted to General Counsel effective April 1, 2026.
• Advisory terms (expected): Dimitrief to serve up to 12 months as advisor on ethylene oxide litigation and receive $22,500 per month plus expense reimbursement.

Why It Matters

• Earnings disclosure: The press release and conference call are the primary source for investors to learn the company’s recent financial performance (earnings, revenue and outlook) for Q4 and full‑year 2025 — key inputs for valuation and near‑term expectations.
• Leadership and legal continuity: Promotion of an internal deputy to General Counsel suggests continuity in legal leadership. Retaining the outgoing GC as a paid advisor (focused on ethylene oxide litigation) signals the company expects ongoing legal work where experienced counsel will be useful; investors should note potential legal risk and related costs disclosed in future filings.
• Next steps for investors: Listen to the February 24 conference call and review the attached press release (Exhibit 99.1) for the detailed financial results and management commentary.